Skip to main content
Dryad

AAV-mediated Inner ear gene delivery triggers mild host immune responses in the mammalian inner ear

Data files

May 01, 2025 version files 79.46 MB

Click names to download individual files

Abstract

Hearing loss is a common disability affecting the world’s population. However, its treatment options are limited. More recently, adeno-associated virus (AAV)-mediated inner ear gene therapy has shown great promise as a treatment for hereditary hearing loss. However, the host immune responses to AAV-mediated gene therapy in the mammalian inner ear are not well understood. In this study, two serotypes of AAV vectors were injected individually into the mouse inner ear to evaluate the host innate and adaptive immune responses up to one month after inner ear gene delivery. Our results suggest that the host innate and adaptive immune responses to AAV-mediated inner ear gene delivery are limited and mild, which is favorable for its clinical translation.